MiR-25-3p promotes the proliferation of triple negative breast cancer by targeting BTG2
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
MiR-25-3p promotes the proliferation of triple negative breast cancer by targeting BTG2
Authors
Keywords
TNBC, miR-25-3p, Proliferation, BTG2, AKT, ERK
Journal
Molecular Cancer
Volume 17, Issue 1, Pages -
Publisher
Springer Nature
Online
2018-01-08
DOI
10.1186/s12943-017-0754-0
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- MiR-106b and miR-93 regulate cell progression by suppression of PTEN via PI3K/Akt pathway in breast cancer
- (2017) Nana Li et al. Cell Death & Disease
- MicroRNA epigenetic signatures in human disease
- (2016) Klara Piletič et al. ARCHIVES OF TOXICOLOGY
- Chemotherapy for Triple-Negative Breast Cancer: Is More Better?
- (2016) Erica L. Mayer et al. JOURNAL OF CLINICAL ONCOLOGY
- MiR-27a-3p functions as an oncogene in gastric cancer by targeting BTG2
- (2016) Lin Zhou et al. Oncotarget
- miR-25 modulates NSCLC cell radio-sensitivity through directly inhibiting BTG2 expression
- (2015) Zhiwei He et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Global cancer statistics, 2012
- (2015) Lindsey A. Torre et al. CA-A CANCER JOURNAL FOR CLINICIANS
- miR-25 Modulates Invasiveness and Dissemination of Human Prostate Cancer Cells via Regulation of αv- and α6-Integrin Expression
- (2015) E. Zoni et al. CANCER RESEARCH
- BTG2: A rising star of tumor suppressors (Review)
- (2014) BIJING MAO et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- Crosstalk with Cancer-Associated Fibroblasts Increases the Growth and Radiation Survival of Cervical Cancer Cells
- (2014) Tang-Yuan Chu et al. RADIATION RESEARCH
- Signals regulating necrosis of cardiomyoblast by BTG2/TIS21/PC3 via activation of GSK3β and opening of mitochondrial permeability transition pore in response to H2O2
- (2013) Yong Won Choi et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- MicroRNA-25 functions as a potential tumor suppressor in colon cancer by targeting Smad7
- (2013) Qiang Li et al. CANCER LETTERS
- The miR-106b∼25 cluster promotes bypass of doxorubicin-induced senescence and increase in motility and invasion by targeting the E-cadherin transcriptional activator EP300
- (2013) Y Zhou et al. CELL DEATH AND DIFFERENTIATION
- miR-25 promotes gastric cancer cells growth and motility by targeting RECK
- (2013) Hongying Zhao et al. MOLECULAR AND CELLULAR BIOCHEMISTRY
- BTG2 inhibits the proliferation, invasion, and apoptosis of MDA-MB-231 triple-negative breast cancer cells
- (2013) Yan-jun Zhang et al. TUMOR BIOLOGY
- Down-Regulation of the miR-25 and miR-30d Contributes to the Development of Anaplastic Thyroid Carcinoma Targeting the Polycomb Protein EZH2
- (2012) Francesco Esposito et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Androgen-regulated miR-32 targets BTG2 and is overexpressed in castration-resistant prostate cancer
- (2012) S E Jalava et al. ONCOGENE
- The miR-106b-25 cluster targets Smad7, activates TGF-β signaling and induces EMT and tumor initiating cell characteristics downstream of Six1 in human breast cancer
- (2012) A L Smith et al. ONCOGENE
- BTG2 loss and miR-21 upregulation contribute to prostate cell transformation by inducing luminal markers expression and epithelial–mesenchymal transition
- (2012) V Coppola et al. ONCOGENE
- microRNAs: Master Regulators as Potential Therapeutics in Cancer
- (2011) Michela Garofalo et al. Annual Review of Pharmacology and Toxicology
- Aberrant Expression of the p53-Inducible Antiproliferative Gene BTG2 in Hepatocellular Carcinoma is Associated with Overexpression of the Cell Cycle-Related Proteins
- (2011) Zhimin Zhang et al. CELL BIOCHEMISTRY AND BIOPHYSICS
- miR-25 targets TNF-related apoptosis inducing ligand (TRAIL) death receptor-4 and promotes apoptosis resistance in cholangiocarcinoma
- (2011) Nataliya Razumilava et al. HEPATOLOGY
- Breast tumor progression induced by loss of BTG2 expression is inhibited by targeted therapy with the ErbB/HER inhibitor lapatinib
- (2011) F Takahashi et al. ONCOGENE
- Up-regulation of cell cycle arrest protein BTG2 correlates with increased overall survival in breast cancer, as detected by immunohistochemistry using tissue microarray
- (2010) Elin Möllerström et al. BMC CANCER
- Modulation of K-Ras-Dependent Lung Tumorigenesis by MicroRNA-21
- (2010) Mark E. Hatley et al. CANCER CELL
- Targeting microRNAs in cancer: rationale, strategies and challenges
- (2010) Ramiro Garzon et al. NATURE REVIEWS DRUG DISCOVERY
- Triple-Negative Breast Cancer
- (2010) William D. Foulkes et al. NEW ENGLAND JOURNAL OF MEDICINE
- Regulation of the cell cycle gene, BTG2, by miR-21 in human laryngeal carcinoma
- (2009) Min Liu et al. CELL RESEARCH
- The mammalian anti-proliferative BTG/Tob protein family
- (2009) G. Sebastiaan Winkler JOURNAL OF CELLULAR PHYSIOLOGY
- Impact of BTG2 expression on proliferation and invasion of gastric cancer cells in vitro
- (2009) Lin Zhang et al. MOLECULAR BIOLOGY REPORTS
- Emerging Role of miR-106b-25/miR-17-92 Clusters in the Control of Transforming Growth Factor Signaling
- (2008) F. Petrocca et al. CANCER RESEARCH
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now